Selective recruitment of ApoB-48 for the assembly of VLDL in rat triacylglycerol-enriched hepatocytes

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 7, 1996, Pages 889-897

  Coussons, Peter J ^a   Bourgeois, Catherine S ^a   Wiggins, David ^a   Gibbons, Geoffrey F ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

apolipoprotein B; hepatocyte culture; regulation; triacylglycerol; VLDL

Indexed keywords

APOLIPOPROTEIN B; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DENSITY; CONTROLLED STUDY; ENZYME DEGRADATION; FATTY ACID TRANSPORT; GENETIC REGULATION; HORMONAL REGULATION; HYPERTRIGLYCERIDEMIA; LIPOGENESIS; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN PROCESSING; RAT; STEM CELL;

EID: 0029944354     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.7.889     Document Type: Article

References (47)

1. Pullinger CR, North JD, Teng B-B, Rifici VA, Ronhild de Brito AE, Scott J. The apolipoprotein B gene is constitutively expressed in HepG2 cells: regulation of secretion by oleic acid, albumin, and insulin, and measurement of the mRNA half-life. J Lipid Res. 1989;30:1065-1077.
2. Dashti N, Williams DL, Alaupovic P. Effects of oleate and insulin on the production rates and cellular mRNA concentrations of apolipoproteins in HepG2 cells. J Lipid Res. 1989;30:1365-1373.
3. Borén J, Wettesten M, Sjoberg A, Thorlin T, Bondjers G, Wiklund O, Olofsson S-O. The assembly and secretion of apoB 100 containing lipoproteins in HepG2 cells: evidence for different sites for protein synthesis and lipoprotein assembly. J Biol Chem. 1990;265:10556-10564.
4. Wang H, Chen X, Fisher EA. N-3 fatty acids stimulate intracellular degradation of apoprotein B in rat hepatocytes. J clin Invest. 1993;91:1380-1389.
5. Dixon JL, Ginsberg HN. Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells. J Lipid Res. 1993;34:167-179.
6. Sparks JD, Sparks CE. Hormonal regulation of lipoprotein assembly and secretion. Curr Opin Lipidol. 1993;4:177-186.
7. Sparks JD, Sparks CE. Insulin regulation of triacylglycerol-rich lipoprotein synthesis and secretion. Biochim Biophys Acta. 1994;1215:9-32.
8. Cianflone K, Dahan S, Monge JC, Sniderman AD. Pathogenesis of carbohydrate-induced hypertriglyceridemia using HepG2 cells as a model system. Arterioscler Thromb. 1992;12:271-277.
9. Davis RA, Boogaerts JR. Intrahepatic assembly of very low density lipoproteins: effect of fatty acids on triacylglycerol and apolipoprotein synthesis. J Biol chem. 1982;257:10908-10913.
10. Salam WH, Wilcox HG, Heimberg M. Effects of oleic acid on the biosynthesis of lipoprotein apoproteins and distribution into the very-low-density lipoprotein by the isolated perfused rat liver. Biochem J. 1988;251:809-816.
11. Patsch W, Tamai T, Schonfeld G. Effect of fatty acids on lipid and apoprotein secretion and association in hepatocyte cultures. J Clin Invest. 1983;72:371-378.
12. Davis RA, Clinton GM, Borchardt RA, Malone-McNeal M, Tan T, Lattier GR. Intrahepatic assembly of very low density lipoproteins: phosphorylation of small molecular weight apolipoprotein B. J Biol Chem. 1984;259:3383-3386.
13. Gibbons GF. Assembly and secretion of hepatic very-low-density lipoprotein. Biochem J. 1990;268:1-13.
14. Coleman RA, Haynes EB, Sand TM, Davis RA, Developmental coordinate expression of triacylglycerol and small molecular weight apoB synthesis and secretion by rat hepatocytes. J Lipid Res. 1988;29:33-42.
15. Boogaerts JR, Malone-McNeal M, Archambault-Schexnayder J, Davis RA. Dietary carbohydrate induces lipogenesis and very-low-density lipoprotein synthesis. Am J Physiol. 1984;246:E77-E83.
16. Gibbons GF, Bartlett SM, Sparks CE, Sparks JD. Extracellular fatty acids are not utilized directly for the synthesis of very-low-density lipoprotein in primary cultures of rat hepatocytes. Biochem J. 1992;287:749-753.
17. Taskinen M-R, Beltz WF, Harper I, Fields RM, Schonfeld G, Grundy SM, Howard BV. Effects of NIDDM on very-low-density lipoprotein triglyceride and apolipoprotein B metabolism: studies before and after sulfonylurea therapy. Diabetes. 1986;35:1268-1277.
18. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res. 1987;28:613-628.
19. Howard BV, Abbott WGH, Egusa G, Taskinen MR. Coordination of very low-density lipoprotein triglyceride and apolipoprotein B metabolism in humans: effects of obesity and non-insulin-dependent diabetes. Am Heart J. 1987;113:522-526.
20. Taskinen M-R, Packard CJ, Shepherd J. Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM. Diabetes. 1990;39:1017-1027.
21. Packard CJ, Munro A, Lorimer AR, Gotto AM, Shepherd J. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects. J Clin Invest. 1984;74:2178-2192.
22. Eisenberg S. Lipoprotein abnormalities in hypertriglyceridemia: significance in atherosclerosis. Am Heart J. 1987;113:555-561.
23. Windmueller HG, Spaeth AE. Regulated biosynthesis and divergent metabolism of three forms of hepatic apolipoprotein B in the rat. J Lipid Res. 1985;26:70-81.
24. Bartlett SM, Gibbons GF. Short- and longer-term regulation of very-low-density lipoprotein secretion by insulin, dexamethasone and lipogenic substrates in cultured hepatocytes: a biphasic effect of insulin. Biochem J. 1988;249:37-43.
25. Van Harken DR, Dixon CW, Heimberg M. Hepatic lipid metabolism in experimental diabetes, V: the effect of concentration of oleate on metabolism of triglycerides and on ketogenesis. J Biol Chem. 1969;244:2278-2285.
26. Otway S, Robinson DS. The use of a non-ionic detergent (Triton WR-1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions. J Physiol (Lond). 1967;190:321-332.
27. Fisher WR, Schumaker VN. Isolation and characterization of apolipoprotein B-100. Methods Enzymol. 1986;128A:247-262.
28. Egusa G, Brady DW, Grundy SM, Howard BV. Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B. J Lipid Res. 1983;24:1261-1267.
29. Sparks JD, Sparks CE. Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. J Biol Chem. 1990;265:8854-8862.
30. Sparks JD, Zolfaghari R, Sparks CE, Smith HC, Fisher EA. Impaired hepatic apolipoprotein B and E translation in streptozotocin diabetic rats. J Clin Invest. 1992;89:1418-1430.
31. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
32. Edelstein C, Scanu AM. Precautionary measures for collecting blood destined for lipoprotein isolation. Methods Enzymol. 1986;128:151-155.
33. Folch J, Lees M, Sloane-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497-509.
34. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem. 1969;6:24-30.
35. Duerden JM, Gibbons GF. Restoration in vitro of normal rates of very-low-density lipoprotein triacylglycerol and apoprotein B secretion in hepatocyte cultures from diabetic rats. Biochem J. 1993;294:167-171.
36. Wang H, Yao Z, Fisher EA. The effects of n-3 fatty acids on the secretion of carboxyl-terminally truncated forms of human apoprotein B. J Biol Chem. 1994;269:18514-18520.
37. Leighton JK, Joyner J, Zamarripa J, Deines M, Davis RA. Fasting decreases apolipoprotein B mRNA editing and the secretion of small molecular weight apoB by rat hepatocytes: evidence that the total amount of apoB secreted is regulated post-transcriptionally. J Lipid Res. 1990;31:1663-1668.
38. Inui Y, Giannoni F, Funahashi T, Davidson NO. REPR and complementation factor(s) interact to modulate rat apolipoprotein B mRNA editing in response to alterations in cellular cholesterol flux. J Lipid Res. 1994;35:1477-1489.
39. Thorngate FE, Raghow R, Wilcox HG, Werner CS, Heimberg M, Elam MB. Insulin promotes the biosynthesis and secretion of apolipoprotein B-48 by altering apolipoprotein B mRNA editing. Proc Natl Acad Sci U S A. 1994;91:5392-5396.
40. Yao ZM, Blackhart BD, Linton MF, Taylor SM, Young SG, Mc-Carthy BJ. Expression of carboxyl-terminally truncated forms of human apolipoprotein B in rat hepatoma cells: evidence that the length of apolipoprotein B has a major effect on the buoyant density of the secreted lipoproteins. J Biol Chem. 1991;266:3300-3308.
41. Borén J, Graham L, Wettesten M, Scott J, White A, Olofsson S-O. The assembly and secretion of apoB 100-containing lipoproteins in HepG2 cells: apoB 100 is cotranslationally integrated into lipoproteins. J Biol Chem. 1992;267:9858-9867.
42. Graham DL, Knott TJ, Jones TC, Pease RJ, Pullinger CR, Scott J. Carboxyl-terminal truncation of apolipoprotein B results in gradual loss of the ability to form buoyant lipoproteins in cultured human and rat liver cell lines. Biochemistry. 1991;30:5616-5621.
43. Spring DJ, Lee SM, Puppione DL, Phillips M, Elovson J, Schumaker VN. Identification of a neutral lipid core in a transiently expressed and secreted lipoprotein containing an apoB-48-like apolipoprotein. J Lipid Res. 1992;33:233-240.
44. Borén J, Rustaeus S, Olofsson SO. Studies on the assembly of apolipoprotein B-100- and B-48-containing very low density lipoproteins in McA-RH7777 cells. J Biol Chem. 1994;269:25879-25888.
45. Swift LL. Assembly of very low density lipoproteins in rat liver: a study of nascent particles recovered from the rough endoplasmic reticulum. J Lipid Res. 1995;36:395-406.
46. Levy E, Marcel Y, Deckelbaum RJ, Milne R, Lepage G, Seidman E, Bendayan M, Roy CC. Intestinal apoB synthesis, lipids, and lipoproteins in chylomicron retention disease. J Lipid Res. 1987;28:1263-1274.
47. Patel S, Pessah M, Beucler I, Navarro J, Infante R. Chylomicron retention disease: exclusion of apolipoprotein B gene defects and detection of mRNA editing in an affected family. Atherosclerosis. 1994;108:201-207.